A Design Map: From Public Purpose to Market Effect
The GovVC question can now be made more precise by connecting four ideas: the friction that leaves a venture unfunded, the public objective chosen in response, the ownership and financial terms that shape behaviour, and the private reaction those choices are meant to induce. This checkpoint turns those relationships into a working judgment. Given a proposed programme, the reader should be able to say what gap it targets, how its design is supposed to change the market, and what remains unproven.
Diagnose the gap before choosing the fund
A programme begins with an observation, but an observation is not yet a diagnosis. “There is too little venture capital” could mean that a region lacks investors and networks, that the seed stage has too few funds, that a crisis has temporarily frozen follow-on finance, or that a technology takes too long and costs too much to test. These conditions can look similar from the perspective of a founder who cannot raise a round. They call for different public responses.
Suppose the problem is a region with universities and technically capable entrepreneurs but little local VC. A scope-enhancing programme might try to seed the regional market, attract experienced managers, and create relationships with follow-on investors. Its purpose is not simply to fund a fixed number of local companies. It is to change the conditions that make local investment scarce. Evidence of progress might therefore include the development of deal flow and investor capability, as well as company financing. A fund that invests widely but leaves the local market no more able to evaluate or finance ventures may have supplied capital without repairing the diagnosed gap.
Now change the diagnosis. Imagine a country with investors and networks but a shortage of seed or scale-up capital across many sectors. That is closer to a scale-enhancing objective. A broad fund, or one concentrated on the underserved stage, could be appropriate. Its relevant test is whether the supply of capital becomes deeper or more continuous. It would be a mistake to demand that it target one technology merely because another kind of public programme should do so.
A costly, long experiment creates a third case. Here the issue may not be geography or the total number of funds. Private investors can see the opportunity but cannot justify paying for years of uncertain experimentation within a typical closed-end fund. A public vehicle might provide staged, patient finance that allows information to be produced. The design should still specify what evidence the experiments are expected to generate and when a continuation decision will be made. “Patient” cannot mean that every project remains funded regardless of what is learned.
The distinction between scope and scale is thus a distinction between changing the composition of investment and increasing its overall supply. They can coexist, but they should not be silently substituted for one another. A targeted fund may accept a portfolio that looks unlike a broad private portfolio because its purpose is to reach a neglected segment. A scale fund may be failing if it merely replaces deals that private investors were already ready to finance.